In mouse colon carcinogenesis a significantly increased expression of CD133 have been observed, assessed by immunohistochemistry, in early neoplastic lesions which tended to decrease with tumor development [17] and an increased CD133 expression was reported in Dukes A compared to Dukes B and C colon cancers [16]. This evidence concerns the gene PROM1 and malignant colon neoplasm.